Multimodal Treatment Planning for Pain

 

In the United States, opioid misuse has become an epidemic, costing the United States 78.5 billion dollars. There are over 250 million opioid prescriptions each year in the US, and misuse of opioids in children is in the hundreds of thousands. For adults, misuse is in the millions. There is not a clear understanding about multimodal treatment options for pain that have similar results to opioid medications. This course is designed to teach best practices for treating pain using non-pharmacological interventions or a combination of alternative pain management treatment and medications.

$19.95

Hours: 1.00
REL-PI-0-P4PC31

Certificates

Certificates provided by accrediting body (9 Match)

California Board of Registered Nursing

1.0 HOURS


Provider approved by the California Board of Registered Nursing, CEP# 13791

Nurses will receive 1.00 contact hours for participating in this course.

District of Columbia Board of Nursing

1.0 HOURS


DC-RN -- District of Columbia Board of Nursing Approved Continuing Education program (CE Provider #50-290).

Nurses will receive 1.00 contact hours for participating in this course.

Florida Board of Nursing CE

1.0 HOURS


Florida Board of Nursing CE Provider #: 50-290

Nurses will receive 1.00 contact hours for participating in this course.

American Nurses Credentialing Center

1.0 HOURS


Relias, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses will receive 1.00 contact hours for participating in this course.

Georgia Board of Nursing

1.0 HOURS


Georgia Board of Nursing CE Provider #: 50-290

Nurses will receive 1.00 contact hours for participating in this course.

Accreditation Council for Continuing Medical Education

1.0 HOURS


Relias LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Relias LLC designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

South Carolina Board of Nursing

1.0 HOURS


This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CE provider #50-290) CE Broker Course # 20-[Custom_Code]

Florida Board of Medicine

1.0 HOURS


Florida Board of Medicine CE Provider #: 50-290

Florida Physician Assistants

1.0 HOURS


Course Details

Course Code: REL-PI-0-P4PC31
Hours: 1
Type: Online Course
Content Expiration Date: 9/30/2020
Learning Objectives:
Identify barriers to pain management
Name risk factors for opioid abuse
Define multimodal treatments for managing pain
Describe how to implement multimodal treatments

Outline:
Section 1: Introduction A. About This Course B. Learning Objectives Section 2: The Barriers to Pain Management A. Meet Joanna B. Identifying the Risk of Opioid Abuse C. The Problem with Pain Management D. Review E. Summary Section 3: Using a Multimodal Treatment Plan for Pain A. Multimodal Treatment Options B. Physical Therapy C. Biofeedback D. Deep Breathing E. Guided Imagery F. Mindful Meditation G. Acupressure H. Yoga I. Aromatherapy J. Heat Therapy K. Cold Therapy L. Chiropractic Care M. Transcutaneous Electrical Nerve Stimulation. N. Non-Opioid Analgesics O. Review P. Summary Section 4: Applying Multimodal Treatments A. Best Practices B. Review C. Summary Section 5: Conclusion A. Summary B. Course Contributor C. References D. Congratulations!

Staff Writer: Jessica Cairns, RN, RAC-CT, CMAC
Jessica has almost 15 years of experience in nursing and 10 years in MDS/PAC working with organizations for the purposes of assessment, reimbursement, training, organizational, and leadership development. In these roles, she has acted as a consultant and auditor. Jessica has written content for diverse healthcare topics, including health and human services, compliance and more.  Disclosure: Jessica Cairns, RN, RAC-CT, CMAC has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Expert Reviewer: Jack M. Gorman, MD
Dr. Gorman MD is a key medical consultant for Care Management Technologies. He founded Franklin Behavioral Healthcare Consultants in 2010, which provides expert guidance to biotech companies and to health care organizations. He is currently CEO and Chief Scientific Officer. Prior to this, Dr. Gorman was Chief Scientific Officer and Senior Vice-President of both Comprehensive NeuroScience, Inc. and Care Management Technologies Inc. In those positions, he used his two decades of experience in neuroscience, psychiatry, and psychopharmacology to help develop new programs in behavioral health care management and CNS drug development. Dr. Gorman was a summa cum laude graduate of the University of Pennsylvania, received his medical degree from the College of Physicians and Surgeons of Columbia University, and completed residency and fellowship training in the Department of Psychiatry of Columbia University/New York State Psychiatric Institute program. He was on the faculty of Columbia University from 1981 to 2002, becoming Lieber Professor, Vice-chair for Research and Director of the Lieber Center for Schizophrenia Research. He then became Klingenstein Professor and Chair of the Department of Psychiatry of the Mount Sinai School of Medicine. Dr. Gorman was elected a fellow of the American College of Neuropsychopharmacology, has authored or co-authored more than 400 scientific articles and chapters, was continuously funded by the National Institutes of Health for his research from 1981 until 2006, and received three research grants from the Brain and Behavior Institute (formerly NARSAD). He is one of the most frequently cited authors in psychiatry and neuroscience literature. Dr. Gorman is co-editor of the textbooks “Treatments that Work,” now in its third edition, “Comprehensive Textbook of AIDS Psychiatry,” and author of “The Essential Guide to Psychiatric Drugs,” which appeared in its fourth edition in 2007. His newest book, co-authored with Sara E. Gorman, is "Denying to the Grave: Why We Ignore the Facts that Will Save Us," is now available. Disclosure: Jack M. Gorman, MD has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Target Audience:
The target audience for this course is: entry and intermediate level Nurses; entry level Physician Assistants; entry level Physicians; in the following settings: All Healthcare Settings.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.
Accommodations
If you require special accommodations to complete this module, please contact Relias Customer Support by calling (800) 381-2321 or emailing support@relias.com